文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

解析炎性细胞因子和低氧预处理对间充质基质细胞(MSC)来源的可溶性蛋白和细胞外囊泡(EV)的促血管生成潜力的影响。

Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs).

机构信息

Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy; U.O. Cellular Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

U.O. Cellular Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

出版信息

Biomaterials. 2021 Feb;269:120633. doi: 10.1016/j.biomaterials.2020.120633. Epub 2020 Dec 28.


DOI:10.1016/j.biomaterials.2020.120633
PMID:33453634
Abstract

Mesenchymal stromal cells (MSCs) are characterized by a regulatory phenotype and respond promptly to the environmental signals modulating their secretory activity. An appropriate preconditioning may induce MSCs to release secretomes with an enhanced regenerative potential. However, it fails to take into account that secretomes are composed by both soluble factors and extracellular vesicles (EVs), whose functions could be altered differently by the preconditioning approach. Here we demonstrate that the MSC secretome is strongly modulated by the simultaneous stimulation with hypoxia and pro-inflammatory cytokines, used to mimic the harsh environment present at the site of injury. We observed that the environmental variations strongly influenced the angiogenic potential of the different secretome fractions. Upon inflammation, the pro-angiogenic capacity of the soluble component of the MSC secretome was strongly inhibited, regardless of the oxygen level, while the EV-encapsulated component was not significantly affected by the inflammatory stimuli. These effects were accompanied by the modulation of the secreted proteins. On one hand, inflammation-activated MSCs release proteins mainly involved in the interaction with innate immune cells and in tissue remodeling/repair; on the other hand, when MSCs are not exposed to an inflamed environment, they respond to the different oxygen levels modulating the expression of proteins involved in the angiogenic process. The cargo content (in terms of miRNAs) of the corresponding EV fractions was less sensitive to the influence of the external stimuli. Our findings suggest that the therapeutic efficacy of MSC-based therapies could be enhanced by selecting the appropriate preconditioning approach and carefully discriminating its effects on the different secretome components.

摘要

间充质基质细胞(MSCs)的特征是具有调节表型,并对调节其分泌活性的环境信号迅速作出反应。适当的预处理可以诱导 MSCs 释放具有增强再生潜能的分泌组。然而,它没有考虑到分泌组由可溶性因子和细胞外囊泡(EVs)组成,其功能可能因预处理方法的不同而发生不同的改变。在这里,我们证明 MSC 分泌组受到缺氧和促炎细胞因子的同时刺激的强烈调节,这些因子用于模拟损伤部位的恶劣环境。我们观察到环境变化强烈影响不同分泌组部分的血管生成潜力。在炎症时,MSC 分泌组可溶性成分的促血管生成能力受到强烈抑制,无论氧水平如何,而 EV 包裹成分不受炎症刺激的显著影响。这些作用伴随着分泌蛋白的调节。一方面,炎症激活的 MSCs 释放主要涉及与先天免疫细胞相互作用和组织重塑/修复的蛋白;另一方面,当 MSCs 不暴露于炎症环境中时,它们会对不同的氧水平作出反应,调节参与血管生成过程的蛋白的表达。相应的 EV 部分的货物含量(以 miRNA 形式)对外部刺激的影响较小。我们的发现表明,通过选择适当的预处理方法并仔细区分其对不同分泌组成分的影响,可以增强基于 MSC 的治疗的治疗效果。

相似文献

[1]
Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs).

Biomaterials. 2021-2

[2]
Effects of preconditioning with TNFα and IFNγ in angiogenic potential of mesenchymal stromal cell-derived extracellular vesicles.

Front Cell Dev Biol. 2023-12-21

[3]
Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.

Stem Cell Res Ther. 2020-4-28

[4]
Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.

Stem Cell Res Ther. 2020-12-14

[5]
Menstrual blood-derived mesenchymal stromal cells: impact of preconditioning on the cargo of extracellular vesicles as potential therapeutics.

Stem Cell Res Ther. 2023-7-28

[6]
Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions.

Cytotherapy. 2022-12

[7]
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.

Stem Cells Transl Med. 2016-6

[8]
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.

Front Immunol. 2018-11-9

[9]
Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content.

J Cell Physiol. 2018-10-30

[10]
Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.

Front Immunol. 2022

引用本文的文献

[1]
Extracellular vesicles and their mimetics: clinical application prospects in medical aesthetics.

Burns Trauma. 2025-5-17

[2]
From bench to bedside: the research status and application opportunity of extracellular vesicles and their engineering strategies in the treatment of skin defects.

J Nanobiotechnology. 2025-5-25

[3]
Microenvironmental Modulation for Therapeutic Efficacy of Extracellular Vesicles.

Adv Sci (Weinh). 2025-5

[4]
Engineered Extracellular Vesicles as a New Class of Nanomedicine.

Chem Bio Eng. 2024-10-28

[5]
Pathogenic and therapeutic roles of extracellular vesicles in sepsis.

Front Immunol. 2025-2-4

[6]
Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?

Stem Cell Res Ther. 2025-2-4

[7]
Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Biomedicines. 2024-12-14

[8]
Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL. Mice.

Int J Mol Sci. 2024-11-25

[9]
Hypoxic Human Microglia Promote Angiogenesis Through Extracellular Vesicle Release.

Int J Mol Sci. 2024-11-21

[10]
Exosome-mediated renal protection: Halting the progression of fibrosis.

Genes Dis. 2023-9-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索